Finorify

MDGL

Madrigal Pharmaceuticals

$544.50-1.04%

Price

MDGL daily closing price
Market cap
$12.55 billion
Volume
186.0K
Sector
Healthcare

Madrigal Pharmaceuticals (MDGL) last closed at $544.50, on a daily price path from October 21, 2025 to October 21, 2026. Overview is that price path. Performance is the change in the close over the periods Finorify shows on the stock screen. Financials, cash flow, and margins come from reported quarters. Valuation lists the latest ratios. This snapshot is the Finorify stock screen for MDGL, covered for search and blurred for visitors.

Performance

  • 1D-2.05%
  • 5D-0.45%
  • 1M-11.73%
  • 3M-15.72%
  • 6M-13.45%
  • 1Y+4.09%
  • 5Y+463.64%

Financials

MDGL revenueQ2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26

Over the latest four reported periods ending March 31, 2026, Madrigal Pharmaceuticals reported revenue of $948.7 million.

The prior window totaled $76.8 million, so the latest window is higher than that stretch.

Operating cash flow in the latest window was -$223.5 million.

Free cash flow in the latest window was -$228.2 million.

These amounts are taken from Madrigal Pharmaceuticals's SEC filings and are a snapshot as of July 26, 2026. They are not a live price, and they are not a recommendation to buy or sell. Finorify uses the same filings to draw the charts inside the app.

A few ratios from those statements: Profitability: ROE -17.4% (0 of 100). Leverage: D/E 0.63× (75 of 100). Cash generation: FCF margin -24.1% (0 of 100). Net margin: -30.3% (0 of 100). Liquidity: Current 3.50× (100 of 100).

Cash Flow

MDGL free cash flowQ3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26

Margins

MDGL operating margin

Valuation

P/S (TTM)
13.23

Insights

Finorify has not written notes for MDGL in this snapshot.

Read the live analysis in Finorify

Charts, news, and the written notes are in the app. You can open five distinct stocks free. After that, the stock screen is a Finorify Pro feature.

Open MDGL in Finorify